Last updated on June 2016

Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Alopecia | Hypertrichosis | Hirsutism
  • Age: Between 18 - 45 Years
  • Gender: Male
  • Other:
    Healthy male, aged 18-45 years
    Clinically visible terminal hair growth on thighs

You may not be eligible for this study if the following are true:

  • Damaged skin in or around test sites
    History of any acute (e.g. acute infections) or chronic illness or known skin cancer
    that might confound the results of the trial
    History or clinical signs of keloids or hypertrophic scars
    Immunological disorders such as alopecia areata, and systemic lupus erythematosus
    Current or within 2 weeks prior to first dosing use of vasodilating drugs (e.g.
    Pentoxifyllin, nitroglycerine) or anticoagulating drugs (e.g. heparine, cumarines,
    new oral anticoagulants)
    Current or within 3 months prior to first dosing use of anti-inflammatory medication,
    corticosteroids or immunosuppressive drugs taken for more than 2 consecutive weeks
    Current or within 3 months prior to first dosing use of medication with hair growth
    modifying properties like minoxidil, diazoxid, cyclosporine, antiandrogens
    Current or within 12 months prior to first dosing intake of anabolics or 5-alpha
    reductase inhibitors
    Current or within one week prior to first dosing use of any topical drugs on the legs

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.